Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
Donald Trump
World Cup
Artificial Intelligence
South America
Social Media
Stock Markets
Drones
Elon Musk
Soccer
Education
Military
Published • loading... • Updated

Phase 1 CAR T-cell therapy trial likely to open soon to SSc patients

Summary by Scleroderma News
Adults with diffuse and limited SSc are expected to soon start entering a safety study of ADI-001, targeting B-cells, at increasing doses.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Scleroderma NewsScleroderma News

Phase 1 CAR T-cell therapy trial likely to open soon to SSc patients

Adults with diffuse and limited SSc are expected to soon start entering a safety study of ADI-001, targeting B-cells, at increasing doses.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Scleroderma News broke the news in on Tuesday, March 18, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

United States

United States

News
For You
SearchBlindspotLocal